Form 4 Tracker
Editas Medicine, Inc.
EDIT

6 insider filings · Latest: Mar 12, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 3, 2026Mar 4 9:56 PMGilmore Neil O'NeillDirector, CEO
Sale
5,394$2.02$10.9K263,693(D)

View →

Mar 3, 2026Mar 4 9:49 PMAmy ParisonSVP, Chief Financial Officer
Sale
474$2.02$95715,434(D)

View →

Mar 3, 2026Mar 4 9:48 PMLinda BurklyEVP, CHIEF SCIENTIFIC OFFICER
Sale
749$2.02$1.5K68,028(D)

View →

Mar 3, 2026Feb 27 9:35 PMO'Neill Gilmore Neil
Proposed Sale
6,000$1.89$11.3K

View →

Dec 3, 2025Dec 1 10:06 PMO'Neill Gilmore Neil
Proposed Sale
7,000$2.50$17.5K

View →

Sep 3, 2025Aug 29 8:34 PMO'Neill Gilmore Neil
Proposed Sale
7,000$2.73$19.1K

View →

Sep 3, 2025Aug 29 8:22 PMBurkly Linda
Proposed Sale
800$2.73$2.2K

View →

Jul 31, 2025Jul 30 8:15 PMBurkly Linda
Proposed Sale
7,500$3.46$25.9K

View →

Jun 3, 2025Jun 2 9:32 PMO'Neill Gilmore Neil
Proposed Sale
20,000$1.87$37.4K

View →

Mar 3, 2025Feb 28 9:40 PMO'Neill Gilmore Neil
Proposed Sale
35,000$1.86$65.1K

View →

Mar 3, 2025Feb 28 9:39 PMLucera Erick
Proposed Sale
8,000$1.86$14.9K

View →

Mar 3, 2025Feb 28 9:35 PMBurkly Linda
Proposed Sale
6,000$1.86$11.2K

View →

Sep 3, 2024Aug 29 8:19 PMO'Neill Gilmore Neil
Proposed Sale
3,000$3.92$11.8K

View →

Sep 3, 2024Aug 29 8:17 PMMei Baisong
Proposed Sale
1,000$3.92$3.9K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 12, 2026Mar 16 8:37 PMGilmore Neil O'NeillDirector, CEO
Grant/Award
1,015,200$2.541,015,200(D)

View →

Mar 12, 2026Mar 16 8:35 PMAmy ParisonSVP, Chief Financial Officer
Grant/Award
292,856$2.54292,856(D)

View →

Mar 12, 2026Mar 16 8:34 PMLinda BurklyEVP, CHIEF SCIENTIFIC OFFICER
Grant/Award
292,856$2.54292,856(D)

View →